CAMBRIDGE, Mass., Jan. 3 /PRNewswire/ --
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced today that its
presentation to the JP Morgan H&Q Healthcare Conference will be webcast live
and may be accessed under the 'investor relations' tab at http://www.millennium.com.
(Photo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Mark Levin, chairman and chief executive officer of Millennium, will
provide an overview of the company and review corporate goals for 2002. His
presentation will be delivered at 10:00 a.m. (Pacific Time) on Wednesday,
January 9, 2002 from the Grand Ballroom of the Westin St. Francis Hotel in San
Francisco. The presentation will be archived for 30 days.
Millennium, a leading biopharmaceutical company, applies its comprehensive
and integrated science and technology platform for the discovery and
development of breakthrough therapeutic and predictive medicine products, with
a goal of delivering personalized medicine. Through the industrialization of
this gene-to-patient platform, millennium is also striving to accelerate the
process of drug discovery and development. Headquartered in Cambridge,
Massachusetts, Millennium currently employs more than 1,500 people.
Editor's Note: This release is available on Millennium's website at
http://www.millennium.com
Contact:
Gina Brazier, Investor Relations
Millennium Pharmaceuticals, Inc.
(617) 551-3611
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/114562.html
CONTACT:
Gina Brazier, Investor Relations of
Millennium Pharmaceuticals, Inc., +1-617-551-3611
|
